logo
logo

Brain Mapping Pioneer Omniscient Neurotechnology Raises Aud 40 Million In Series B Financing

Jul 19, 2021•almost 4 years ago

Round Type

series b

SydneyHealthcareManufacturing

Description

Omniscient Neurotechnology (“o8tTM”), a pioneering brain mapping technology company, today announced the completion of an AUD 40 million Series B financing round. The funding was led by family offices and high-net worth individuals, including Hancock Prospecting’s Executive Chairman Mrs. Gina Rinehart, and prominent fund manager Will Vicars.

Company Information

Company

Omniscient Neurotechnology

Location

Sydney, New South Wales, Australia

About

Omniscient Neurotechnology (o8t™) is a pioneering brain mapping company that is revolutionizing brain care with data. Using innovations in medical imaging and machine learning, Omniscient builds applications capable of mapping and analyzing “brain networks” which are formed by the electrical connections within a person’s brain. Such insights are illuminating the neural processes that make us human and helping clinicians and researchers understand, diagnose, and treat complex neurological and mental illnesses. Omniscient is a leader in the field of “connectomics” – the study of the brain’s connections. It recently launched Quicktome™, the world’s first medical device to harness this vital data for neurological care, providing neurosurgeons brain network information prior to life-changing surgery. The company is headquartered in Sydney, Australia with offices globally.

Related People